Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-037473

President and CEO sold 33,260 shares at an average $21.64 ($719,735)

  • President and CEO acquired 73,015 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Walker Neal · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-01 Exercise or conversion : show line 1 in the form +73,015 1,265,442 D
2021-06-02 Sale : show line 2 in the form −27,743 $21.51 $596,696 1,237,699 D
2021-06-02 Sale : show line 3 in the form −5,517 $22.30 $123,038 1,232,182 D
Open-market sales · 33,260 sh · avg $21.64 · $719,735

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-01 Exercise or conversion : show line 4 in the form Restricted Stock Units −73,015 0 D
Loading xslF345X03/doc4.xml…